Fig. 4
Subgroup analysis of Lp(a) on ischemic stroke in non-valvular atrial fibrillation patients. Note: Interactions of Lp(a) with sex, age, anticoagulants, and CHA2DS2-VASc score were P = 0.590, P = 0.216, P < 0.001, and P = 0.207 for Lp(a) categories and P = 0.113, P = 0.888, P < 0.001, and P = 0.078 for continuous Lp(a) [Log-Lp(a)], respectively. Model 1: adjusted for sex, age, and ethnicity; Model 2: adjusted for CHA2DS2-VASc score; Model 3: adjusted for ethnicity, CHA2DS2-VASc score, anticoagulants, lipid-lowering medications, triglycerides, total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, apolipoprotein A1, apolipoprotein B, and red-cell distribution width. Lp(a), Lipoprotein(a); Log, log-transformed; OR, odds ratio; CI, confidence interval